References
- Connors L H, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J Prot Fold Dis 2003; 10: 160–184
- Jacobson D R, Pastore R D, Yaghoubian R, Kane I, Gallo G, Buck F S, Buxbaum J N. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336: 466–473
- Janunger T, Anan I, Holmgren G, Lovheim O, Ohlsson P I, Suhr O B, Tashima K. Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser. Amyloid: Int J Exp Clin Invest 2000; 7: 137–140
- Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi Asl K, Benson M D, Donat J R. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003; 60: 1625–1630
- Anan I, El-Salhy M, Nyhlin N, Suhr O B. Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy. Transplantation 2000; 70: 794–799
- Xiao W, Oefner P J. Denaturing high-performance liquid chromatography: A review. Hum Mutat 2001; 17: 439–474
- Nichols W C, Benson M D. Hereditary amyloidosis: detection of variant prealbumin genes by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1990; 37: 44–53
- Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S. Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 2001; 57: 135–137
- Suhr O B, Svendsen I H, Andersson R, Danielsson A, Holmgren G, Ranlov P J. Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med 2003; 254: 225–235
- Svendsen I H, Steensgaard-Hansen F, Nordvag B Y. A clinical, echocardiographic and genetic characterization of a Danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathy. Eur Heart J 1998; 19: 782–789
- Lobato L, Beirao I, Silva M, Bravo F, Silvestre F, Guimaraes S, Sousa A, Noel L H, Sequeiros J. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Nephrol Dial Transplant 2003; 18: 532–538
- Suhr O B, Ericzon B G, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002; 8: 787–794
- Stangou A J, Hawkins P N, Heaton N D, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys M B, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998; 66: 229–233
- Pomfret E A, Lewis W D, Jenkins R L, Bergethon P, Dubrey S W, Reisinger J, Falk R H, Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998; 65: 918–925
- Olofsson B O, Backman C, Karp K, Suhr O B. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002; 73: 745–751
- Hornsten R, Wiklund U, Olofsson B O, Jensen S M, Suhr O B. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004; 78: 112–116